Drug intelligence / Profile preview

poly-L-lactic acid + sodium hyaluronate

Development stage
Unknown
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intradermal, Subcutaneous
01

Overview

Poly-L-lactic acid + sodium hyaluronate is an injectable combination product used primarily for facial rejuvenation and soft tissue augmentation. Poly-L-lactic acid (PLLA) is a synthetic, biocompatible, biodegradable polymer that acts as a collagen biostimulator. After injection, PLLA microparticles induce a controlled subclinical inflammatory response that stimulates fibroblasts to produce new type I collagen over several months, resulting in gradual volume restoration and improvement of skin structure. Sodium hyaluronate (hyaluronic acid or HA) is a naturally occurring glycosaminoglycan with strong hydrophilic properties; it provides immediate volumization by attracting water into the extracellular matrix of the dermis, improving hydration and skin texture. The combination leverages the complementary mechanisms of both agents—HA offers instant filling effects while PLLA induces long-term neocollagenesis for sustained results. This hybrid approach aims to achieve natural-looking facial volume restoration with improved skin quality and reduced risk of overtreatment or excessive fibrosis compared to PLLA alone[2][4][5][8]. The product can be used for deep wrinkles, laxity correction, significant tissue defects, or general facial rejuvenation.

Brand names
LENISNA
Other names
PLLA + HApoly-L-lactic acid and hyaluronic acid combinationpolylactic acid and sodium hyaluronate filler

Beyond the preview

Go deeper on poly-L-lactic acid + sodium hyaluronate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on poly-L-lactic acid + sodium hyaluronate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call